Indication
Congenital athymia
Congenital athymia is an ultra-rare, life-threatening primary immunodeficiency disorder characterized by the complete absence of a functional thymus at birth. Read more about Congenital athymia
2 drugs 2 manufacturers
Drugs that treat it
Common Congenital athymia therapies.
RETHYMIC (thymus tissue-agdc)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCongenital athymia is an ultra-rare, life-threatening primary immunodeficiency disorder characterized by the complete absence of a functional thymus at birth.
Primarily affecting pediatric patients, the condition frequently occurs as part of complex genetic syndromes, such as complete DiGeorge syndrome, 22q11.2 deletion syndrome, CHARGE syndrome, or isolated mutations in genes essential for thymic organogenesis, such as FOXN1 or PAX1.
Pathophysiologically, the lack of thymic tissue prevents the maturation and selection of T lymphocytes, resulting in profound T-cell lymphopenia.
Consequently, affected infants present with extreme susceptibility to severe, recurrent infections, failure to thrive, and life-threatening immune dysregulation, including autologous graft-versus-host-like disease.
- nih.gov
Congenital athymia is an ultra-rare, life-threatening primary immunodeficiency disorder characterized by the complete absence of a functional thymus at birth Primarily affecting pediatric patients, the condition frequently occurs as part of complex genetic syndromes, such as complete DiGeorge syndrome, 22q11.2 deletion syndrome, CHARGE syndrome, or isolated mutations in genes essential for thymic organogenesis, such as FOXN1 or PAX1 Pathophysiologically, the lack of thymic tissue prevents the ma...
- primaryimmune.org
Congenital athymia is an ultra-rare, life-threatening primary immunodeficiency disorder characterized by the complete absence of a functional thymus at birth Pathophysiologically, the lack of thymic tissue prevents the maturation and selection of T lymphocytes, resulting in profound T-cell lymphopenia
- rarediseases.org
Primarily affecting pediatric patients, the condition frequently occurs as part of complex genetic syndromes, such as complete DiGeorge syndrome, 22q11.2 deletion syndrome, CHARGE syndrome, or isolated mutations in genes essential for thymic organogenesis, such as FOXN1 or PAX1 Consequently, affected infants present with extreme susceptibility to severe, recurrent infections, failure to thrive, and life-threatening immune dysregulation, including autologous graft-versus-host-like disease
Personalize your experience
Follow Congenital athymia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.